8-K/AThe WireRoutine
Company Update
Filed Jun 18, 2026 · 11d ago · Accession 0001628280-26-044260
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Esperion Therapeutics, Inc.
- Ticker
- ESPR
- CIK
- 1434868
- Form type
- 8-K/A
- Filing date
- Jun 18, 2026
- Report date
- Apr 2, 2026
- Document
- espr-20260402.htm
- Size
- 5.9 MB